PEGylation technology and key applications are introduced by this
topical volume. Basic physical and chemical properties of PEG as basis
for altering/improving in vivo behaviour of PEG-conjugates such as
increased stability, improved PK/PD, and decreased immunogenicity, are
discussed. Furthermore, chemical and enzymatic strategies for the
coupling and the conjugate characterization are reported. Following
chapters describe approved and marketed PEG-proteins and
PEG-oligonucleotides as well as conjugates in various stages of clinical
development.